---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-010416"
form_type: "8-K"
ticker: "MTNB"
cik: "0001582554"
company_name: "Matinas BioPharma Holdings, Inc."
filed_at: "2025-03-14T23:59:59+00:00"
generated_at: "2026-05-24T18:17:29.689881+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Matinas BioPharma Chairman Eric Ende resigns from Board effective March 14

## Summary
- Eric Ende resigned as Board member and Chairman on March 14, 2025.
- Resignation is due to other professional obligations, not a disagreement.
- No replacement for Chairman or Board seat has been announced.

## SEC filing metadata
- accession: 0001493152-25-010416
- form_type: 8-K
- ticker: MTNB
- cik: 0001582554
- company_name: Matinas BioPharma Holdings, Inc.
- filed_at: 2025-03-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1582554/000149315225010416/0001493152-25-010416-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1582554/000149315225010416/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-010416
- JSON: https://secwatch.observer/filing/0001493152-25-010416.json
- Plain text: https://secwatch.observer/filing/0001493152-25-010416.txt

## Key facts
- Executive change
  Eric Ende resigned as Chairman of the Board at Matinas BioPharma Holdings, Inc..
  - Action: resigned
  - Role: Chairman of the Board
  source text: On March 13, 2025, Eric Ende informed the Board of Directors (the “ Board ”) of Matinas BioPharma Holdings, Inc. (the “ Company ”) that he was resigning as a member of the Board and as Chairman of the Board effective March 14, 2025, due to his other professional obligations.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1582554/000149315225010416/0001493152-25-010416-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.